title: Human herpesvirus 6 and cytomegalovirus infections in children with human immunodeficiency virus infection and cancer.
abstract: OBJECTIVE
  Measure the prevalence of human herpesvirus 6 (HHV-6) and cytomegalovirus (CMV) infections in children and adolescents with HIV infection and malignancy.
  
  
  METHODS
  Semiquantitative polymerase chain reaction and serology were used to test for HHV-6 and CMV infections in 31 cases (HIV-infected children with cancer), 56 HIV controls (HIV-infected children without cancer) and 30 cancer controls (HIV-uninfected children with cancer).
  
  
  RESULTS
  In cases, HIV controls and cancer controls, HHV-6 DNA was detected in 29, 39 and 34%, respectively, and CMV DNA was detected in 13, 4 and 7%, respectively. Four cases (13%) and no HIV controls or cancer controls harbored HHV-6 subtype A (P = 0.014). In cases, HIV controls and cancer controls, the prevalence of HHV-6 antibodies was 58, 68 and 93%, respectively, and the prevalence of CMV antibodies was 71, 48 and 70%, respectively. HHV-6 seroprevalence was lower in cases than in cancer controls (P = 0.002), even with adjustments for age and CD4 concentrations; however, HHV-6 infection rates (presence of HHV-6 DNA and/or HHV-6 antibodies) were similar in all groups. Stratification showed that CMV infection was more common in younger patients (ages < 8 years) without severe immune suppression (CD4 concentration >200 cells/microl) than in HIV controls (odds ration, 10.343; 95% confidence interval, 1.65, 121.57). Geometric mean titers of serum anti-CMV antibodies, but not anti-HHV-6 antibodies, were higher in cases (1:71) than in HIV controls (1:33) (P = 0.005).
  
  
  CONCLUSIONS
  HHV-6 and CMV infections were common among children with HIV infection and cancer. CMV seropositivity also was associated with cancer in younger HIV-infected patients who did not have severe immune suppression. HHV-6A was detected only in HIV-infected children with cancer.
authors.affiliation: Department of Pediatrics, Division of Infectious Diseases, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
authors.forename: Charles T
authors.initials: CT
authors.lastname: Leach
authors.forename: Brad H
authors.initials: BH
authors.lastname: Pollock
authors.forename: Kenneth L
authors.initials: KL
authors.lastname: McClain
authors.forename: Richard T
authors.initials: RT
authors.lastname: Parmley
authors.forename: Sharon B
authors.initials: SB
authors.lastname: Murphy
authors.forename: Hal B
authors.initials: HB
authors.lastname: Jenson
mesh_terms: D000293:Adolescent; D000328:Adult; D016022:Case-Control Studies; D002648:Child; D002675:Child, Preschool; D003587:Cytomegalovirus / Q000235:genetics* / Q000472:pathogenicity; D003586:Cytomegalovirus Infections / Q000453:epidemiology*; D004279:DNA, Viral / Q000032:analysis; D005260:Female; D015658:HIV Infections / Q000150:complications*; D015654:Herpesvirus 6, Human / Q000235:genetics* / Q000472:pathogenicity; D006801:Humans; D007223:Infant; D008297:Male; D009369:Neoplasms / Q000150:complications* / Q000821:virology*; D016133:Polymerase Chain Reaction; D015995:Prevalence; D019349:Roseolovirus Infections / Q000453:epidemiology*
chemical_list: D004279:DNA, Viral